Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability & Proliferation Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) utilizes WST-8, a water-soluble tetrazolium salt, for sensitive colorimetric quantification of viable cells (APExBIO). The assay detects mitochondrial dehydrogenase activity in living cells, correlating signal intensity to cell number. CCK-8 is more sensitive and less toxic than MTT, XTT, or MTS assays (Ding et al. 2016). The readout is rapid, one-step, and compatible with high-throughput screening. CCK-8 has become a standard in cancer research, cytotoxicity, and osteoblast differentiation workflows (see related article).

Biological Rationale

Accurate measurement of cell proliferation and viability is fundamental in biomedical research. Understanding cellular responses to genetic modification, drugs, or environmental stressors requires quantitative assays. The CCK-8 assay addresses the need for rapid, sensitive, and reproducible quantification of living cells. Traditional methods, such as trypan blue exclusion or MTT assays, suffer from lower sensitivity, increased manual steps, and cell toxicity (Ding et al. 2016). Water-soluble tetrazolium salt-based assays, notably those using WST-8, overcome these barriers by generating a soluble formazan dye, eliminating solubilization steps and reducing assay artifacts. The strong correlation between mitochondrial dehydrogenase activity and viable cell number enables precise, non-destructive endpoint measurement (contrasts with guidance on workflow optimization).

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

CCK-8 employs WST-8, a water-soluble tetrazolium salt, as its core reagent. In the presence of living cells, mitochondrial dehydrogenases catalyze the reduction of WST-8 to a yellow-orange formazan product. The reaction requires intracellular NADH or NADPH as electron donors. The amount of formazan produced is directly proportional to the number of metabolically active (viable) cells. The formazan is water-soluble, allowing direct measurement at 450 nm using a microplate reader without additional extraction or solubilization steps. The reaction can be performed at 37°C in common cell culture media, and the signal is stable for over 1 hour, enabling flexible readout times (CCK-8, APExBIO).

Evidence & Benchmarks

• CCK-8 detects as few as 100–1,000 cells/well with high linearity (R² >0.99) in standard 96-well plate formats (Ding et al. 2016).
• WST-8-based CCK-8 is less cytotoxic than MTT, allowing for subsequent downstream analyses using the same plate (internal article).
• CCK-8 provides a 2- to 3-fold greater signal-to-background ratio compared to XTT or MTS assays, improving sensitivity in cytotoxicity testing (Ding et al. 2016).
• In osteoblast differentiation studies, CCK-8 enables quantitative assessment of proliferation and viability in MC3T3-E1 and C3H10T1/2 cells, facilitating mechanistic studies of Prmt1-Ddx17-Sh2b1 axis (Ding et al. 2016, Table 1).
• The K1018 kit from APExBIO supports high-throughput screening with consistent inter-assay and intra-assay reproducibility (CV <5%) (product page).

Applications, Limits & Misconceptions

CCK-8 is widely used in cancer research, neurodegenerative disease studies, drug screening, and toxicology. The assay is suitable for adherent and suspension cells, including primary cells and established lines. It enables real-time monitoring of cell proliferation, cytotoxicity, and metabolic activity. In osteoblast research, CCK-8 quantifies the effects of genetic or pharmacological manipulations on cell viability and differentiation (Ding et al. 2016). Compared to legacy assays, CCK-8 offers greater dynamic range, operational simplicity, and reduced sample loss. For a strategic perspective on WST-8 assay integration in translational workflows, see this article (which this review updates with new evidence from Ddx17 research).

Common Pitfalls or Misconceptions

• CCK-8 measures mitochondrial dehydrogenase activity, not absolute cell number; metabolic state changes can confound interpretation.
• Dead or highly stressed cells may show reduced signal, but some residual activity can persist, leading to overestimation of viability in late apoptosis/early necrosis.
• The assay is incompatible with strong reducing agents (e.g., high ascorbate, DTT) or highly colored compounds that interfere with 450 nm absorbance.
• Very high cell densities (>1 x 10⁶ cells/well) may saturate the signal, requiring optimization for each cell type and plate format.
• Not suitable for direct measurement in complex tissue samples or in vivo environments; optimized for in vitro cell culture systems only.

Workflow Integration & Parameters

To use the Cell Counting Kit-8 (CCK-8), cells are seeded in a 96- or 384-well plate and treated as desired. The WST-8 reagent is added directly to the culture medium (typically 10 μL CCK-8 per 100 μL medium per well). Plates are incubated at 37°C for 1–4 hours. Absorbance is measured at 450 nm using a standard microplate reader. No washing, cell harvesting, or organic solvents are required. The signal remains stable for at least 1 hour, permitting flexible data acquisition. Researchers can perform kinetic analyses by taking multiple readings. The same plate can be used for additional staining or downstream molecular assays, as CCK-8 is non-destructive (product documentation). Compare this to the guidance on troubleshooting and optimization in this scenario-based article (which this review extends with specific focus on osteoblast and metabolic applications).

Conclusion & Outlook

Cell Counting Kit-8 (CCK-8), as offered by APExBIO, represents a robust, sensitive, and user-friendly solution for cell viability, proliferation, and cytotoxicity assays. Its WST-8 chemistry delivers reproducible results across a wide range of cell types and experimental conditions. CCK-8 is central to current workflows in cancer research, drug screening, and osteoblast differentiation studies, as demonstrated in the context of the Prmt1-Ddx17-Sh2b1 axis (Ding et al. 2016). Future developments may integrate CCK-8 with multiplexed omics or imaging platforms to further expand its utility in high-content screening and systems biology.